US FDA inspection closed at its Injectable Facility with Zero 483 observations: Lupin
New Delhi [India], June 14 (ANI): Lupin Limited, a global pharmaceutical company, said that the United States Food and Drug Administration (FDA) has completed an inspection of its Injectable facility at Nagpur.According to the stock market filing with the National Stock Exchange, Lupin says the U.S. FDA carried out the inspection between June 10 to June 13, 2024, and concluded with zero 483 observations.The pharma major s